Nicole Valdivieso
General Counsel bei HCW BIOLOGICS INC.
Profil
Nicole Valdivieso is currently the Director-Legal Affairs at HCW Biologics Inc. She previously worked as an In-House Counsel at KOS Pharmaceuticals, Inc. and as an Attorney-Patent at Conoco, Inc. She also worked as an Attorney at Lott & Friedland PA and as Counsel Attorney at Lott & Fischer PL.
Ms. Valdivieso has a degree in undergraduate studies from Ferris State University (Michigan) and a graduate degree from the University of Miami School of Law.
Aktive Positionen von Nicole Valdivieso
Unternehmen | Position | Beginn |
---|---|---|
HCW BIOLOGICS INC. | General Counsel | 01.06.2020 |
Ehemalige bekannte Positionen von Nicole Valdivieso
Unternehmen | Position | Ende |
---|---|---|
Kain Spielman PA | General Counsel | 01.01.2019 |
Lott & Fischer PL | General Counsel | 01.01.2014 |
Lott & Friedland PA | General Counsel | 01.01.2009 |
Conoco, Inc. | Corporate Officer/Principal | 01.01.2002 |
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | General Counsel | 01.01.2001 |
Ausbildung von Nicole Valdivieso
Ferris State University (Michigan) | Undergraduate Degree |
University of Miami School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
HCW BIOLOGICS INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Health Technology |
Conoco, Inc. | Energy Minerals |
Lott & Fischer PL | |
Kain Spielman PA | |
Lott & Friedland PA |